What Ovid Therapeutics Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 2 |
| Total trades | 0 | 10 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 1,530,403 |
| Disposed | 0 | 20,197 |
| Net activity | +0 | +1,510,206 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Carter Charles Ross | Chief Financial Officer | Jul 06 | Grant / award · A | +50,000 | — | — | 94,375 |
| Papadopoulos Stelios | Director | Apr 07 | Grant / award · A | +17,578 | $2.56 | +$45K | 217,578 |
| Friedman Bart | Director | Apr 07 | Grant / award · A | +8,789 | $2.56 | +$22.5K | 8,789 |
| Fitzgerald Kevin Joseph | Director | Apr 07 | Grant / award · A | +17,578 | $2.56 | +$45K | 17,578 |
| Levin Jeremy M | Executive Chairman | Mar 23 | Exercise / conversion · M | +47,333 | $1.40 | +$66.3K | 3,735,048 |
| Rona Jeffrey A | CBFO | Feb 26 | Grant / award · A | +68,125 | — | — | 156,313 |
| Alexander Margaret A. | President and CEO | Feb 23 | Sale for tax withholding · S | −11,656 | $1.45 | −$16.9K | 61,750 |
| Rona Jeffrey A | CBFO | Feb 23 | Sale for tax withholding · S | −8,541 | $1.45 | −$12.4K | 88,188 |
| Levin Jeremy M | CEO | Dec 15 | Derivative Conversion · C | +71,000 | — | — | 3,687,715 |
| Takeda Pharmaceutical Co Ltd | 10% owner | Dec 08 | Derivative Conversion · C | +1,250,000 | — | — | 7,000,000 |
| Alexander Margaret A. | President and COO | Feb 26 | Sale for tax withholding · S | −5,279 | $0.56 | −$2.96K | 73,406 |
| Rona Jeffrey A | CBFO | Feb 26 | Sale for tax withholding · S | −3,902 | $0.56 | −$2.19K | 67,973 |
| Alexander Margaret A. | President and COO | Feb 20 | Grant / award · A | +43,750 | — | — | 78,685 |
| Rona Jeffrey A | CBFO | Feb 20 | Grant / award · A | +43,750 | — | — | 71,875 |
| Alexander Margaret A. | President and COO | Jan 27 | Open-market buy · P | +6,810 | $0.73 | +$4.97K | 34,935 |
| Levin Jeremy M | CEO | Mar 18 | Open-market buy · P | +18,248 | $2.76 | +$50.4K | 3,616,715 |
| Perone Thomas Michael | General Counsel, Secretary | Feb 22 | Grant / award · A | +28,125 | — | — | 28,125 |
| Rona Jeffrey A | CBFO | Feb 22 | Grant / award · A | +28,125 | — | — | 28,125 |
| Tardio Jason | Chief Operating Officer | Feb 22 | Grant / award · A | +28,125 | — | — | 28,125 |
| Levin Jeremy M | CEO | Dec 04 | Gift · G | −573,275 | — | — | 3,598,467 |
Loading...
